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Previews(dopaminergic, cholinergic, and motor
neurons), cardiomyocytes, and hepato-
cytes, and will facilitate development of
in vivo cell fate conversion as a therapeu-
tic strategy for neurological diseases and
other disorders.
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Eliminating hematopoietic stem cells (HSCs) with DNA damage is necessary to maintain the homeostasis
of HSCs, but the mechanisms underlying this apoptotic elimination are unclear. Now in Cell Stem Cell,
Yamashita et al. (2015) show that Aspp1 coordinates with p53 to protect HSC pool integrity, guarding against
hematological malignancies.Tissue-specific stem cells, including
hematopoietic stem cells (HSCs), are
long-lived, often quiescent cells with self-
renewal properties that maintain organ ho-
meostasis.Althoughquiescence is thought
to protect cells from some endogenous
stresses, it also presents challenges for
the cells in terms of maintaining genomic
integrity. Damaged DNA accumulates
in quiescent HSCs because they are ob-
liged to use error-prone non-homologous
recombination mechanism (also called
non-homologous end joining, or NHEJ) to
repair their damaged DNA. In contrast,
cycling HSCs repair DNA damage via
error-proof homologous recombination
(HR), but DNA replication also generates
random mutations. Hence, regardless of
the proliferation status of HSCs, there
must be mechanisms that can effectively
eliminate damaged cells to prevent hema-
tological malignancies. The tumor sup-
pressor p53 is known to be involved in
DNA-damage-induced apoptosis in both
humanandmouseHSCs,but little is known
about how this property of p53 is gated inresponse to diverse forms of genotoxic
stress to control HSC viability or elimina-
tion. In this issue of Cell Stem Cell, Yama-
shita et al. (2015) reveal Aspp1 as amolec-
ular guardian that protects mouse HSC
integrity in both p53-dependent and -inde-
pendent manners.
The importance of p53 in suppressing
hematopoietic malignancy is supported
by a recent finding that p53mutation pre-
cedes the diagnosis of acute myeloid leu-
kemia (AML), with therapy-related AML
resulting from clonal expansion of pre-
existing mutant-p53-containing HSC
clones (Wong et al., 2015). Importantly,
that study also showed that 50% of
elderly healthy individuals carry one
copy of mutant p53 gene, illustrating that
additional genetic alterations are required
for transformation. Therefore, there is
great interest in identifying additional
proteins that synergize with p53 to defend
against hematological malignancies.
ASPP1, a member of the evolutionarily
conserved apoptosis stimulating proteins
of p53 (ASPP) family, is one such protein.ASPP1, and the related ASPP2, binds p53
and its siblings, p63 and p73, and selec-
tively activates their pro-apoptotic func-
tions (Bergamaschi et al., 2004). Trans-
genic mouse studies have established
Aspp2 as a haploinsufficient tumor sup-
pressor and an activator of p53 (Vives
et al., 2006). ASPP1 has been identified
as an enhancer of apoptosis in human
cord blood stem cells (Milyavsky et al.,
2010), but little is known about the tumor
suppressive function of ASPP1 in adult
HSCs in vivo.
Yamashita et al. first confirmed previ-
ous findings that, after genotoxic stress,
p53 is expressed at higher levels in popu-
lations enriched for hematopoietic stem
and progenitor cells (HSPCs) compared
to those enriched for myeloid progenitor
cells, and they also observed that Aspp1
is more highly expressed in defined HSC
populations than in other hematopoietic
cell types (Yamashita et al., 2015). In
Aspp1-deficient mice, the authors found
an elevated number of white blood cells
and bone marrow myeloid mononuclearCell 17, July 2, 2015 ª2015 Elsevier Inc. 3
Figure 1. The Dual Role of Aspp1 in HSCs
Under steady-state conditions, Aspp1 promotes quiescence (left). Stress such as ionizing radiation prompts HSCs to re-enter the cell cycle (middle) and they thus
become prone to acquire DNA damage during cycling. Aspp1 works both together with and independently of p53 to activate the apoptotic response in heavily
DNA-damaged HSCs (right), while non-damaged HSCs remain proliferative (bottom right).
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Previewscells, but also 1.5- to 2-fold higher levels
of HSC-containing populations (specif-
ically, lineageSca-1+c-Kit+ cells [LSKs]
and long-term HSCs [LT-HSCs]). This
suggests that Aspp1 negatively regulates
HSC proliferation and/or survival. When
Aspp1/ HSCs were subjected to serial
competitive transplantation, compared
to wild-type cells they survived signifi-
cantly longer and showed reduced
apoptosis and upregulated genes associ-
ated with quiescence. A higher proportion
of Aspp1/ HSCs also remained quies-
cent and there was less cell death after
genotoxic stress induced by 5-fluoro-
uracil administration. Similar results were
observed in cultured HSCs from irradi-
ated mice: unlike wild-type HSCs,
Aspp1/ HSCs were able to survive
even with a large number of DNA dam-
age foci and expressed lower levels of
pro-apoptotic genes. Importantly, no
increase of apoptosis was observed
in steady-state HSCs, indicating that
Aspp1 only promotes apoptosis in res-
ponse to stress.
To investigate the relationship be-
tween p53 and these Aspp1-dependent
effects, the authors established mice
with Aspp1/p53/ HSC populations.
Although the number of HSCs in these
mice was increased, levels of apoptosis
were comparable to those observed4 Cell Stem Cell 17, July 2, 2015 ª2015 Elsevin wild-type animals. In serial competitive
transplantation experiments, Aspp1/
p53/HSCsdisplayedenhancedengraft-
ment comparedwith HSCs fromAspp1/
and p53/mice. The double-deficient
mice showed a higher number of HSCs
with severely damaged DNA than p53/
or Aspp1/ mice. Mice transplanted with
aspp1/ HSCs did not develop sponta-
neous lymphoma or leukemia, but the
additional deletion of Aspp1 significantly
increased the lethality of leukemia lym-
phoma in mice receiving p53/ HSC
transplants. Together, these findings sug-
gest that Aspp1 has roles in the regulation
of HSC renewal and the protection against
malignancy, which are both dependent on
and independent of p53.
Aspp1 seems to have distinct roles in
steady-state versus stressed HSCs: in
steady-state conditions, Aspp1 promotes
quiescence and inhibits differentiation
into myeloid progenitors. It is not known
how Aspp1 performs this function. Upon
stress, Aspp1 promotes apoptosis in
HSCs with high levels of DNA damage,
preventing the accumulation of both
quiescent and self-renewing DNA-
damaged HSCs (Figure 1). Interestingly,
elevated p53 induces senescence in pri-
mary fibroblasts but apoptosis in highly
proliferative cancer cells. The precise
mechanisms underlying these distinctier Inc.p53-mediated effects remain largely un-
known, but might be due to elevated
ASPP1 and ASPP2 expression in prolifer-
ating cells. ASPP1 and ASPP2 are tran-
scriptional targets of E2F1, a key promoter
of cell cycle entry (Fogal et al., 2005).
As stress induces HSC proliferation, it
is possible that elevated expression of
ASPP1 may set a threshold for inducing
p53-mediated apoptosis in proliferating
HSCs. It will be interesting to investigate
how ASPP1 increases susceptibility to
both p53-dependent and p53-indepen-
dent apoptosis when the HSCs enter the
cell cycle after genotoxic stress.
In terms of human hematological malig-
nancies, it is important to note that—
unlike in solid tumors—the TP53 gene is
mutated infrequently, except in certain
tumor subtypes with complex karyotypes
or after chemotherapy (Holmfeldt et al.,
2013; Wong et al., 2015). How can this
be reconciled with the observed role of
p53 in eliminating HSCs with DNA dam-
age? One possibility is that the relatively
low levels of somatic mutations in leuke-
mias and lymphomas are not sufficient
to activate p53-dependent apoptosis,
and malignant cells evade p53-indepen-
dent apoptosis through upregulation of
anti-apoptotic proteins such as Bcl-2
(Tsujimoto et al., 1985). It is also possible
that the role of p53 in maintaining HSC
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Previewsself-renewal might provide selective
pressure to retain functional p53. Since
ASPP1 is a guardian of HSC integrity,
similar pressure may also exist to
maintain ASPP1 in hematopoietic malig-
nancies. Interestingly, genomic data
suggest that ASPP1 is not commonly
mutated or deleted in human hematologi-
cal cancers, but frequent downregulation
of ASPP1 mRNA, such as through pro-
moter methylation, has been observed
(Agirre et al., 2006). In the light of the find-
ings of Yamashita et al., it would therefore
be informative to assess the mutation and
expression status of p53 and ASPP1
together in hematological malignancies.
More broadly, the discovery of p53-
dependent and -independent roles of
Aspp1 in HSCs highlights the need toinvestigate roles of the ASPP proteins
beyond their regulation of p53. Therefore,
the work of Yamashita et al. both unveils
an important aspect of HSC quality con-
trol regulation and provides insights into
the control of apoptosis.REFERENCES
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Generating highly uniform clonogenic stem cell populations has been remarkably difficult with stem cells
from human small and large intestine. A recent report by Wang et al. (2015) demonstrated homogeneous
expansion of human fetal intestinal stem cells, providing a new culture system to understand self-renewing
mechanisms of intestinal stem cells.Intestinal epithelium is a rapidly self-
renewing tissue, and its proliferation is
confined to the bottom of crypts where
the intestinal stem cell niche exists.
Rapidly dividing intestinal stem cells
produce daughter cells that migrate out
of the crypt niche and differentiate into
transit amplifying cells. Recent research
identified niche factors that emanated
from the crypt bottom and regulate in-
testinal stemness. These niche factors
include Wnt, EGF, Notch ligands, and
BMP/TGF-b pathway inhibitors (Sato
et al., 2009; Sato and Clevers, 2013).
Under the presence of defined niche
factors, intestinal stem cells are capable
of forming organoids and indefinitely
self-renew and produce both intestinalstem cells and all types of differentiated
intestinal epithelial cells. In the organoid
culture system, intestinal stem cells also
require niche signals from adjacent
differentiated epithelial cells, such as
Wnt or Notch signaling from Paneth
cells, which precludes the generation
of a uniform clonogenic intestinal stem
cell population (Figure 1). A combination
of two small molecule inhibitors, which
activate Wnt and Notch signaling, miti-
gates dependency of Lgr5+ stem cells
on differentiated niche cells, resulting in
increased clonogenicity of mouse intes-
tinal stem cells, by up to 40% (100-fold
greater than standard culture condi-
tions) (Yin et al., 2014). However, the
combination of chemical inhibitors hasnot been applied to human intestinal
epithelium.
Wang et al. now developed a new
culture system that enables fetal human
intestinal stem cells to indefinitely propa-
gate as uniform highly clonogenic stem
cells, termed ‘‘ground state’’ stem cells
of the human intestine (Wang et al.,
2015). ‘‘Ground state’’ has been originally
used to describe the most primitive state
of embryonic stem cells (ESCs) and has
been useful for understanding the regula-
tion of pluripotency (Hackett and Surani,
2014). Here, in analogy with the ground
state of ESCs, Wang and colleagues
establish the elemental state of tissue
stem cells in vitro. They exploited feeder
layer culture methods originallyCell 17, July 2, 2015 ª2015 Elsevier Inc. 5
